EYE - Rata-rata rega prakiraan National Vision Holdings, Inc.

Logo korporat perusahaan National Vision Holdings, Inc. (EYE)

The financial price action for National Vision Holdings (EYE) illustrates the dynamics of a company developing a closed-loop cycle of optical sales and diagnostics, where the indicator stands at 27.58. The business retains budget-conscious consumers through a comprehensive service suite, although a rift with partners has weakened the system. Stability is ensured by ownership of brands across various price points and a relationship with Walmart. Growth is based on affordable pricing and the scaling of its own proprietary frame lines.

EYE Target konsensus America's Best Contacts & Eyeglasses (04.07.2022 - 22.10.2026)

Rincian analitis perusahaan National Vision Corp (EYE)

EYE (America's Best Contacts & Eyeglasses) — indikator lan laporan sing kasedhiya:
Analisis umum perusahaan:EYE nationalvision.com
Produk dadi National Vision

Investors must find a balance between operating expenses and return on equity. National Vision Holdings (EYE) is developing a business model with low pricing power, relying on high volume and in-house production. The current consensus valuation reflects the arithmetic mean of target prices from leading analysts. This indicator's trend captures phases of market consolidation and fundamental asset revaluation. The stability of the line confirms the resilience of the budget retail strategy.

Karo sapa National Vision Holdings saingan

HCA - Rata-rata rega prakiraan|Tenet Healthcare Corporation - Target konsensus|Fresenius Medical Care AG (FMS) - Rata-rata rega prakiraan|Solventum Inc. - Prakiraan konsensus analis|Rata-rata rega prakiraan Encompass|UHS (uhsinc.com) - Target konsensus|DVA: Rega prakiraan analis|Bagan rega target RadNet|OPCH: Konsensus nilai wajar|Prakiraan konsensus analis SGRY|PINC - Rata-rata rega prakiraan|Prakiraan konsensus analis PGNY (Progyny, Inc.)|Prakiraan konsensus analis ardenthealth.com ARDT|SEM: Target konsensus|Astrana Health Inc - Rega prakiraan analis|Pediatrix Medical Group (MD) - Bagan rega target|Target konsensus U.S. Physical Therapy, Inc.|PNTG (The Pennant Group, Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan organogenesis.com ORGO|Bagan rega target Nutex Health (NUTX)|Auna S.A. - Prakiraan gabungan firma investasi|sbc-holdings.com - Target konsensus|Rega prakiraan analis EOLS (Evolus Corp)|CYH - Bagan rega target|SKIN (The Beauty Health) - Prakiraan gabungan firma investasi|MDWD: Prakiraan konsensus analis|Biote (BTMD) - Prakiraan konsensus analis|Target konsensus JYNT|DCGO (DocGo, Inc) - Rega prakiraan analis|Prakiraan konsensus analis PIII|Target median analis Gain Therapeutics Inc.|Bagan rega target EUDA Health EUDA|Basel Medical (BMGL) - Rata-rata rega prakiraan|CLGN - Bagan rega target|CUPR (Cuprina Holdings Limited) - Prakiraan gabungan firma investasi|CCM: Prakiraan konsensus analis|ashs.com (AMS) - Prakiraan konsensus analis|Bagan rega target MEDIROM Healthcare Group|Bagan rega target ALBT|Target konsensus DHAI (DIH Holding US Inc.)|XAGE (Carmell Corp) - Konsensus nilai wajar|NewGenIvf Group Limited - Target konsensus|ATI Physical Therapy Inc. - Bagan rega target|CareMax - Prakiraan konsensus analis|Target median analis Kindly MD Inc KDLY|LogistiCare (MODV) - Bagan rega target|NVOS - Target median analis|SSY (SunLink Health Systems Inc.) - Prakiraan konsensus analis|imacholdings.comm (BACK) - Target median analis